About Ipilimumab
            
            Class: | Monoclonal antibody (CTLA-4 inhibitor)  
Use: | Treatment of unresectable or metastatic melanoma, adjuvant treatment of melanoma, and treatment of certain types of metastatic colorectal cancer in combination with nivolumab  
Adult dose: | 3 mg/kg IV every 3 weeks for 4 doses, then 10 mg/kg IV every 2 weeks or 3 mg/kg IV every 2 weeks depending on the indication  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended  
Side effects: | Fatigue
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (CTLA-4 inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of unresectable or metastatic melanoma, adjuvant treatment of melanoma, and treatment of certain types of metastatic colorectal cancer in combination with nivolumab
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; may be stored at room temperature for up to 24 hours before use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bristol Myers Squibb Company, U.S.A
                    
                    
                    Package Size
                    40ml Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 110252.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        3 mg/kg IV every 3 weeks for 4 doses, then 10 mg/kg IV every 2 weeks or 3 mg/kg IV every 2 weeks depending on the indication
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, diarrhea, rash, pruritus, colitis, hepatitis, endocrinopathies (e.g., thyroid dysfunction), and infusion-related reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            History of severe hypersensitivity to ipilimumab or any component of the formulation; contraindicated in patients with autoimmune diseases or those receiving immunosuppressive therapy
         
        
        
            
                Important Warnings
            
            Risk of severe immune-mediated adverse reactions; monitor for signs and symptoms of colitis, hepatitis, endocrinopathies, and pneumonitis; may require corticosteroid treatment for severe reactions; not recommended for patients with active infections or those who have received prior organ transplant
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.